Loading...

Pharming Group N.V.

PHGUF•PNK
Healthcare
Biotechnology
$1.64
$-0.11(-6.57%)
U.S. Market opens in 16h 31m

Pharming Group N.V. (PHGUF) Stock Overview

Explore Pharming Group N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio402.46
EPS (TTM)$-0.01
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$1.31
3 Months$2.00
1 Year Target$2.42

PHGUF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pharming Group N.V. (PHGUF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 73.44, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $2.42.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 402.46 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-6.57%
5-Day Change
-6.57%
1-Month Change
8.28%
3-Month Change
-23.95%
6-Month Change
9.00%
Year-to-Date (YTD) Change
-0.91%
1-Year Change
79.08%
3-Year Change
50.00%
5-Year Change
25.77%
All-Time (Max) Change
191.96%

Contact Information

https://www.pharming.com
31 71 524 7400
Darwinweg 24, Leiden, NaN, 2333 CR

Company Facts

404 Employees
IPO DateMay 8, 2002
CountryNL
Actively Trading

Frequently Asked Questions